IDF23-0145 Once-weekly semaglutide in type 2 diabetes patients with heart failure with reduced left ventricular ejection fraction
Source: Diabetes Research and Clinical Practice - Category: Endocrinology Authors: A. Trenas Calero, M.A. P érez-Velasco, J. Sanz-Cánovas, M. Ricci, A. López-Sampalo, M.D. López-Carmona, L. Cobos-Palacios, M.R. Bernal-López, M.D. García de Lucas, S. Jansen-Chaparro, R. Gómez-Huelgas, L.M. Pérez-Belmonte Tags: Cardiovascular Disease Source Type: research
More News: Cardiology | Cardiovascular | Diabetes | Diabetes Type 2 | Endocrinology | Heart | Heart Failure